Supplemental material
Human Vaccines & Immunotherapeutics
Volume 19, 2023 - Issue 1
Meningococcal
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
Elizabeth R. Packnetta Merative (formerly IBM Watson Health), Cambridge, MA, USA
https://orcid.org/0000-0002-4731-6956View further author information
https://orcid.org/0000-0002-4731-6956View further author information, Nicole M. Zimmermana Merative (formerly IBM Watson Health), Cambridge, MA, USAhttps://orcid.org/0000-0001-5819-7844View further author information
https://orcid.org/0000-0001-5819-7844View further author information, Patricia Novyb GSK, Philadelphia, PA, USAhttps://orcid.org/0000-0003-0655-4672View further author information
https://orcid.org/0000-0003-0655-4672View further author information, Laura C. Morgana Merative (formerly IBM Watson Health), Cambridge, MA, USAhttps://orcid.org/0000-0003-1339-9746View further author information
https://orcid.org/0000-0003-1339-9746View further author information, Nnenna Chimec GSK, Rockville, MD, USAhttps://orcid.org/0000-0002-7380-2114View further author information
https://orcid.org/0000-0002-7380-2114View further author information & Parinaz Ghaswallab GSK, Philadelphia, PA, USACorrespondence[email protected]
https://orcid.org/0000-0002-2883-5590View further author information
https://orcid.org/0000-0002-2883-5590View further author information